Loading clinical trials...
Loading clinical trials...
The study evaluated the protein expression levels of FK506-binding protein 12 (FKBP12) in hepatocellular carcinoma (HCC) and paracancerous tissues using immunohistochemistry (IHC). This study aimed to...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
First People's Hospital of Hangzhou
NCT07607769 · Hepatocellular Carcinoma
NCT06472973 · Alcohol Associated Liver Disease, Liver Transplantation
NCT07610551 · HCC - Hepatocellular Carcinoma
NCT07012798 · Hepatocellular Carcinoma (HCC)
NCT07322848 · Hepatocellular Carcinoma (HCC), TACE, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions